This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
K Ali , M Middleton , E Pure & DJ Rader (2005) Apolipoprotein E suppresses the type I inflammatory response in vivo. Circ Res 97, 922–927.
K Asehnoune , D Strassheim , S Mitra , JY Kim & E Abraham (2004) Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 172, 2522–2529.
M Aviram & B Fuhrman (1998) LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants. Mol Cell Biochem 188, 149–159.
S Bellosta , RW Mahley , DA Sanan , J Murata , DL Newland , JM Taylor & RE Pitas (1995) Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J Clin Invest 96, 2170–2179.
GM Bokoch & UG Knaus (2003) NADPH oxidases: not just for leukocytes anymore! Trends Biochem Sci 28, 502–508.
E Borenfreund & JA Puerner (1985) Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 24, 119–124.
HS Choi , JW Kim , YN Cha & C Kim (2006) A quantitative nitroblue tetrazodium assay for determining intracellular superoxide anion production in phagocytic cells. J Immunoassay Immunochem 27, 31–44.
CA Colton , CM Brown , D Cook , LK Needham , Q Xu , M Czapiga , AM Saunders , DE Schmechel , K Rasheed & MP Vitek (2002) APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. Neurobiol Aging 23, 777–785.
CA Colton , M Czapiga , J Snell-Callanan , ON Chernyshev & MP Vitek (2001) Apolipoprotein E acts to increase nitric oxide production in macrophages by stimulating arginine transport. Biochim Biophys Acta 1535, 134–144.
CA Colton , LK Needham , C Brown , D Cook , K Rasheed , JR Burke , WJ Strittmatter , DE Schmechel & MP Vitek (2004) APOE genotype-specific differences in human and mouse macrophage nitric oxide production. J Neuroimmunol 147, 62–67.
M Dietrich , Y Hua , G Block , E Olano , L Packer , JD Morrow , M Hudes , G Abdukeyum , G Rimbach & AM Minihane (2005) Associations between apolipoprotein E genotype and circulating F2-isoprostane levels in humans. Lipids 40, 329–334.
GP Drummen , M Makkinje , AJ Verkleij , JA Op den Kamp & JA Post (2004) Attenuation of lipid peroxidation by antioxidants in rat-1 fibroblasts: comparison of the lipid peroxidation reporter molecules cis-parinaric acid and C11-BODIPY(581/591) in a biological setting. Biochim Biophys Acta 1636, 136–150.
H Duan , CY Lin & T Mazzone (1997) Degradation of macrophage ApoE in a nonlysosomal compartment. Regulation by sterols. J Biol Chem 272, 31156–31162.
S Fazio , VR Babaev , AB Murray , AH Hasty , KJ Carter , LA Gleaves , JB Atkinson & MF Linton (1997) Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci U S A 94, 4647–4652.
R Gao , WL Stone , T Huang , AM Papas & M Qui (2002) The uptake of tocopherols by RAW 264·7 macrophages. Nutr J 1, 2.
N Gotoh , A Graham , E Nikl & VM Darley-Usmar (1993) Inhibition of glutathione synthesis increases the toxicity of oxidized low-density lipoprotein to human monocytes and macrophages. Biochem J 296, Part 1, 151–154.
M Hara , T Matsushima , H Satoh , N Iso-o , H Noto , M Togo , S Kimura , Y Hashimoto & K Tsukamoto (2003) Isoform-dependent cholesterol efflux from macrophages by apolipoprotein E is modulated by cell surface proteoglycans. Arterioscler Thromb Vasc Biol 23, 269–274.
AH Hasty , MF Linton , SJ Brandt , VR Babaev , LA Gleaves & S Fazio (1999) Retroviral gene therapy in ApoE-deficient mice: ApoE expression in the artery wall reduces early foam cell lesion formation. Circulation 99, 2571–2576.
DM Hatters , CA Peters-Libeu & KH Weisgraber (2006) Apolipoprotein E structure: insights into function. Trends Biochem Sci 31, 445–454.
T Hayek , J Oiknine , JG Brook & M Aviram (1994) Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. Biochem Biophys Res Commun 201, 1567–1574.
E Hernandez-Montes , SE Pollard , D Vauzour , L Jofre-Montseny , C Rota , G Rimbach , PD Weinberg & JP Spencer (2006) Activation of glutathione peroxidase via Nrf1 mediates genistein's protection against oxidative endothelial cell injury. Biochem Biophys Res Commun 346, 851–859.
SE Humphries , PJ Talmud , E Hawe , M Bolla , IN Day & GJ Miller (2001) Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet 358, 115–119.
I Jialal , CJ Fuller & BA Huet (1995) The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study. Arterioscler Thromb Vasc Biol 15, 190–198.
C Jolivalt , B Leininger-Muller , P Bertrand , R Herber , Y Christen & G Siest (2000) Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. Free Radic Biol Med 28, 129–140.
ME Kelly , MA Clay , MJ Mistry , HM Hsieh-Li & JA Harmony (1994) Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity. Cell Immunol 159, 124–139.
K Kitagawa , M Matsumoto , K Kuwabara , K Takasawa , S Tanaka , T Sasaki , K Matsushita , T Ohtsuki , T Yanagihara & M Hori (2002) Protective effect of apolipoprotein E against ischemic neuronal injury is mediated through antioxidant action. J Neurosci Res 68, 226–232.
JK Lodge , WL Hall , YM Jeanes & AR Proteggente (2004) Physiological factors influencing vitamin E biokinetics. Ann N Y Acad Sci 1031, 60–73.
AM Minihane , S Khan , EC Leigh-Firbank , P Talmud , JW Wright , MC Murphy , BA Griffin & CM Williams (2000) ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol 20, 1990–1997.
MJ Mistry , MA Clay , ME Kelly , MA Steiner & JA Harmony (1995) Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1A/G1B boundary. Cell Immunol 160, 14–23.
M Miyata & JD Smith (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 14, 55–61.
YM Naguib (1998) A fluorometric method for measurement of peroxyl radical scavenging activities of lipophilic antioxidants. Anal Biochem 265, 290–298.
EH Pap , GP Drummen , VJ Winter , TW Kooij , P Rijken , KW Wirtz , JA Op den Kamp , WJ Hage & JA Post (1999) Ratio-fluorescence microscopy of lipid oxidation in living cells using C11-BODIPY(581/591). FEBS Lett 453, 278–282.
SJ Peroutka & DM Dreon (2000) The value of genotyping for apolipoprotein E alleles in relation to vitamin E supplementation. Eur J Pharmacol 410, 161–163.
T Pham , A Kodvawala & DY Hui (2005) The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity. Biochemistry 44, 7577–7582.
C Ramassamy , D Averill , U Beffert , L Theroux , S Lussier-Cacan , JS Cohn , Y Christen , A Schoofs , J Davignon & J Poirier (2000) Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain. Neurobiol Dis 7, 23–37.
G Rimbach , S De Pascual-Teresa , BA Ewins , S Matsugo , Y Uchida , AM Minihane , R Turner , K VafeiAdou & PD Weinberg (2003) Antioxidant and free radical scavenging activity of isoflavone metabolites. Xenobiotica 33, 913–925.
M Rosenblat & M Aviram (2002) Oxysterol-induced activation of macrophage NADPH-oxidase enhances cell-mediated oxidation of LDL in the atherosclerotic apolipoprotein E deficient mouse: inhibitory role for vitamin E. Atherosclerosis 160, 69–80.
M Rosenblat , R Coleman & M Aviram (2002) Increased macrophage glutathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 163, 17–28.
H Shimano , J Ohsuga , M Shimada , Y Namba , T Gotoda , K Harada , M Katsuki , Y Yazaki & N Yamada (1995) Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall. J Clin Invest 95, 469–476.
JD Smith , M Miyata , M Ginsberg , C Grigaux , E Shmookler & AS Plump (1996) Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J Biol Chem 271, 30647–30655.
Y Song , MJ Stampfer & S Liu (2004) Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141, 137–147.
AK Stannard , DR Riddell , SM Sacre , AD Tagalakis , C Langer , A von Eckardstein , P Cullen , T Athanasopoulos , G Dickson & JS Owen (2001) Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J Biol Chem 276, 46011–46016.
PJ Talmud , JW Stephens , E Hawe , S Demissie , LA Cupples , SJ Hurel , SE Humphries & JM Ordovas (2005) The significant increase in cardiovascular disease risk in APOEɛ4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet 69, 613–622.
A Tamaoka , F Miyatake , S Matsuno , (2000) Apolipoprotein E allele-dependent antioxidant activity in brains with Alzheimer's disease. Neurology 54, 2319–2321.
P Wang-Iverson , JC Gibson & WV Brown (1985) Plasma apolipoprotein secretion by human monocyte-derived macrophages. Biochim Biophys Acta 834, 256–262.
N Yamada , I Inoue , M Kawamura , (1992) Apolipoprotein E prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. J Clin Invest 89, 706–711.
H Yoshida , AH Hasty , AS Major , H Ishiguro , YR Su , LA Gleaves , VR Babaev , MF Linton & S Fazio (2001) Isoform-specific effects of apolipoprotein E on atherogenesis: gene transduction studies in mice. Circulation 104, 2820–2825.
T Yoshida (1996) Determination of reduced and oxidized glutathione in erythrocytes by high-performance liquid chromatography with ultraviolet absorbance detection. J Chromatogr B Biomed Appl 678, 157–164.
M Zeleny , DK Swertfeger , KH Weisgraber & DY Hui (2002) Distinct apolipoprotein E isoform preference for inhibition of smooth muscle cell migration and proliferation. Biochemistry 41, 11820–11823.
J Zhou , AD Struthers & GA Lyles (1999) Differential effects of some cell signalling inhibitors upon nitric oxide synthase expression and nuclear factor-kappaB activation induced by lipopolysaccharide in rat aortic smooth muscle cells. Pharmacol Res 39, 363–373.